nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

01.09.2009 | Original Paper

EpCAM is overexpressed in gastric cancer and its downregulation suppresses proliferation of gastric cancer

verfasst von: Du Wenqi, Wang Li, Cao Shanshan, Chen Bei, Zhang Yafei, Bai Feihu, Liu Jie, Fan Daiming

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 9/2009

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To identify the role of epithelial cellular adhesion molecule (EpCAM) in gastric cancer growth and explore the potential value of EpCAM monoclonal antibody as new therapeutic strategy for gastric cancer.

Methods

The expression of EpCAM was determined by immunohistochemistry staining in gastric cancer tissues, RT-PCR and Western blot in cell lines. EpCAM expression in cell lines was downregulated by small interfering RNA. Then the effects of EpCAM on gastric cancer cell growth in vivo and in vitro were determined by MTT, FCM analysis, clone formation assay and tumor formation assay. Additionally, western blot was used to detect the effect of EpCAM on cell cycle-relevant factor cyclin D1.

Results

EpCAM was found to be overexpressed in gastric cancer tissues and cell lines. Downregulation of EpCAM resulted in a decrease of cell proliferation and cell cycle arrest in AGS and SGC7901 cells, which had high endogenous EpCAM expression. EpCAM downregulation also suppressed tumor formation in nude mice. Moreover, EpCAM repression in gastric cancer cells could downregulate cyclin D1.

Conclusions

EpCAM was a potential oncogene and contributed to the growth of gastric cancer. Our data first provided compelling evidence of potential value of EpCAM in the therapy of gastric cancer in clinic.

Baeuerle PA, Gires O (2007) EpCAM (CD326) finding its role in cancer. Br J Cancer 96:417–423. doi:10.1038/sj.bjc.6603494 PubMedCrossRef

Balzar M, Winter MJ, de Boer CJ et al (1999) The biology of the 17–1A antigen (Ep-CAM). J Mol Med 77:699–712. doi:10.1007/s001099900038 PubMedCrossRef

Braun S, Vogl FD, Naume B et al (2005) A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 353:793–802. doi:10.1056/NEJMoa050434 PubMedCrossRef

Calabrese G, Crescenzi C, Morizio E et al (2001) Assignment of TACSTD1 (alias TROP1, M4S1) to human chromosome 2p21 and refinement of mapping of TACSTD2 (alias TROP2, M1S1) to human chromosome 1p32 by in situ hybridization. Cytogenet Cell Genet 92:164–165. doi:10.1159/000056891 PubMedCrossRef

Chaudry MA, Sales K, Ruf P et al (2007) EpCAM an immunotherapeutic target for gastrointestinal malignancy: current experience and future challenges. Br J Cancer 96:1013–1019. doi:10.1038/sj.bjc.6603505 PubMedCrossRef

Generali D, Berruti A, Brizzi MP et al (2006) Hypoxiainducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer. Clin Cancer Res 12:4562–4568. doi:10.1158/1078-0432.CCR-05-2690 PubMedCrossRef

Gladden AB, Diehl JA (2005) Location, location, location: the role of cyclin D1 nuclear localization in cancer. J Cell Biochem 96:906–913. doi:10.1002/jcb.20613 PubMedCrossRef

Gulubova MV (2002) Expression of cell adhesion molecules, their ligands and tumour necrosis factoralpha in the liver of patients with metastatic gastrointestinal carcinonoms. Histochem J 34:67–77. doi:10.1023/A:1021304227369 PubMedCrossRef

Hartung G, Hofheinz RD, Dencausse Y et al (2005) Adjuvant therapy with edrecolomab versus observation in stage II colon cancer: a multicenter randomized phase III study. Onkologie 28:347–350. doi:10.1159/000084595 PubMedCrossRef

Kaminishi M (2005) Diversity of gastric cancinogenesis. Oncology 69:1–8. doi:10.1159/000086624 PubMedCrossRef

Münz M, Kieu C, Mack B et al (2004) The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation. Oncogene 23:5748–5758. doi:10.1038/sj.onc.1207610 PubMedCrossRef

Osada S, Kanematsu M, Imai H et al (2008) Hepatic fibrosis influences the growth of hepatocellular carcinoma. Hepatogastroenterology 55:184–187PubMed

Osta WA, Chen Y, Mikhitarian K et al (2004) EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res 64:5818–5824. doi:10.1158/0008-5472.CAN-04-0754 PubMedCrossRef

Pantel K, Woelfle U (2005) Detection and molecular characterization of disseminated tumour cells: implication for anticancer therapy. Biochim Biophys Acta 1756:53–64PubMed

Ploverini PJ (1996) Cellular adhesion molecules: newly identified mediators of angiogenesis. Am J Pathol 148:1023–1029

Punt CJ, Nagy A, Douillard JY et al (2002) Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomized study. Lancet 360:671–677. doi:10.1016/S0140-6736(02)09836-7 PubMedCrossRef

Riethmüller G, Schneider-Gädicke E, Schlimok G et al (1994) Randomised trial of monoclonal antibody for adjuvant therapy of resected Duke’s C colorectal carcinoma. Lancet 343:1177–1183. doi:10.1016/S0140-6736(94)92398-1 PubMedCrossRef

Seligson DB, Pantuck AJ, Liu X et al (2004) Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma. Clin Cancer Res 10:2659–2669. doi:10.1158/1078-0432.CCR-1132-03 PubMedCrossRef

Songun I, Litvinov SV, van de Velde CJ et al (2005) Loss of Ep-CAM (CO17–1A) expression predicts survival in patients with gastric cancer. Br J Cancer 92:1767–1772. doi:10.1038/sj.bjc.6602519 PubMedCrossRef

Spizzo G, Obrist P, Ensinger C et al (2002) Prognostic significance of Ep-CAM and Her-2/neu overexpression in invasive breast cancer. Int J Cancer 98:883–888. doi:10.1002/ijc.10270 PubMedCrossRef

Trebak M, Begg GE, Chong JM et al (2001) Oligomeric state of the colon carcinoma-associated glycoprotein GA733–2 (EPCAM/EGP40) and its role in GA733-mediated homotypic cell-cell adhesion. J Biol Chem 276:2299–2309. doi:10.1074/jbc.M004770200 PubMedCrossRef

Trzpis M, McLaughlin PM, de Leij LM et al (2007) Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule. Am J Pathol 171:386–395. doi:10.2353/ajpath.2007.070152 PubMedCrossRef

Varga M, Obrist P, Schneeberger S et al (2004) Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival. Clin Cancer Res 10:3131–3136. doi:10.1158/1078-0432.CCR-03-0528 PubMedCrossRef

Went P, Vasei M, Bubendorf L et al (2006) Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. Br J Cancer 94:128–135. doi:10.1038/sj.bjc.6602924 PubMedCrossRef

Xie X, Wang CY, Cao YX et al (2005) Expression pattern of epithelial cell adhesion molecule on normal and malignant colon tissues. World J Gastroenterol 11:344–347PubMed

Titel: EpCAM is overexpressed in gastric cancer and its downregulation suppresses proliferation of gastric cancer
verfasst von: Du Wenqi
Wang Li
Cao Shanshan
Chen Bei
Zhang Yafei
Bai Feihu
Liu Jie
Fan Daiming
Publikationsdatum: 01.09.2009
Verlag: Springer-Verlag
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 9/2009
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-009-0569-5

Neu im Fachgebiet Onkologie

24.04.2024 | DGIM 2024 | Nachrichten

Springer Medizin

EpCAM is overexpressed in gastric cancer and its downregulation suppresses proliferation of gastric cancer

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2009

Substantially reduced expression of PIAS1 is associated with colon cancer development

A novel role for DYX1C1, a chaperone protein for both Hsp70 and Hsp90, in breast cancer

Herbal extract “Songyou Yin” inhibits tumor growth and prolongs survival in nude mice bearing human hepatocellular carcinoma xenograft with high metastatic potential

Recurrence pattern in glioblastoma multiforme patients treated with anti-angiogenic chemotherapy

A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects

A polymorphism in the promoter region of Ku70/XRCC6, associated with breast cancer risk and oestrogen exposure

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie